Improving functionality improves sleep in patients with active ankylosing spondylitis: Results from the GO-RAISE study

被引：0

作者：

Buchanan, J. ^{[1
]}

Hsu, B. ^{[2
]}

Gathany, T. ^{[1
]}

Parasuraman, S.

机构：

[1] Johnson & Johnson Pharmaceut Serv LLC, Malvern, PA USA

[2] Centocor Res & Dev Inc, Malvern, PA USA

来源：

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2008年 / 26卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：746 / 747

页数：2

共 50 条

[21] Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study
Robert D. Inman
Xenofon Baraliakos
Kay-Geert A. Hermann
Jürgen Braun
Atul Deodhar
Désirée van der Heijde
Stephen Xu
Benjamin Hsu
[J]. Arthritis Research & Therapy, 18
[22] LONG-TERM SAFETY AND EFFICACY OF GOLIMUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS: RESULTS THROUGH 5 YEARS OF THE GO-RAISE TRIAL
Deodhar, A.
Braun, J.
Inman, R.
van der Heijde, D.
Zhou, Y.
Hsu, B.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 283 - 284
[23] The Effect of Golimumab Therapy on Disease Activity and Health-related Quality of Life in Patients with Ankylosing Spondylitis: 2-year Results of the GO-RAISE Trial
van der Heijde, Desiree
Deodhar, Atul
Braun, Juergen
Mack, Michael
Hsu, Benjamin
Gathany, Timothy A.
Inman, Robert D.
Han, Chenglong
[J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (06) : 1095 - 1103
[24] Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo-controlled GO-RAISE study (vol 71, pg 878, 2012)
Braun, J.
Baraliakos, X.
Hermann, K-G A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (05) : 788 - 788
[25] Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE)
van der Heijde, Desiree
Braun, Juergen
Deodhar, Atul
Inman, Robert D.
Xu, Stephen
Mack, Michael E.
Hsu, Benjamin
[J]. RHEUMATOLOGY, 2013, 52 (02) : 321 - 325
[26] THE RELATIONSHIP BETWEEN INFLAMMATION, FATTY LESIONS AND SYNDESMOPHYTES IN AS: RESULTS FROM GO-RAISE
Baraliakos, X.
Hermann, K. G.
Xu, S.
Hsu, B.
Braun, J.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 772 - 772
[27] Head-to-head comparison of three enthesitis indices in the ankylosing spondylitis anti-TNF-α trial of golimumab (GO-RAISE)
van der Heijde, D.
Braun, J.
Davis, J. C., Jr.
Deodhar, A.
Inman, R. D.
Mack, M.
Beutler, A.
Hsu, B.
[J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S362 - S362
[28] Achieving Ankylosing Spondylitis Disease Activity Score-C-Reactive Protein Major Improvement and Inactive Disease in Patients with Ankylosing Spondylitis after Treatment with Golimumab is Associated with Normalized Health Related Quality of Life: 2-Year Results from GO-RAISE
Inman, Robert
Deodhar, Atul
Braun, Juergen
Mack, Michael
Hsu, Benjamin
Gathany, Tim
Han, Chenglong
Van der Heijde, Desiree
[J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1012 - 1012
[29] Golimumab, a new, human, TNF-alpha antibody administered as a monthly subcutaneous injection in ankylosing spondylitis (AS): 24-week efficacy and safety results of the randomized, placebocontrolled GO-RAISE study
Braun, Juergen
Davis, John C.
Van der Heijde, Desiree
Diekman, Laura
Sieper, Joachim
Kim, Sung Il
Mack, Michael
Han, John
Hsu, Benjamin
Beutler, Anna
Inman, Robert
[J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4236 - 4237
[30] ACHIEVING ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE C-REACTIVE PROTEIN MAJOR IMPROVEMENT AND INACTIVE DISEASE IN PATIENTS WITH ANKYLOSING SPONDYLITIS AFTER TREATMENT WITH GOLIMUMAB IS ASSOCIATED WITH NORMALIZED HEALTH-RELATED QUALITY OF LIFE: 2-YEAR RESULTS FROM GO-RAISE
van der Heijde, Desiree
Deodhar, Atul
Braun, Jurgen
Mack, Michael
Hsu, Ben
Gathany, Tim
Han, Chenglong
Inman, Robert D.
[J]. RHEUMATOLOGY, 2013, 52 : 161 - 162

← 1 2 3 4 5 →